Description: Nanjing Hicin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, marketing, and sale of pharmaceutical preparations and synthetic chemicals in China. The company offers antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for cardio-cerebral system, and immuno-modulate agents. It also provides technical transferring services. The company also exports APIs; omeprazole sodium and cefepime hydrochloride for injections; and lansoprazole tablets to South-Asian countries, South-American countries, and European countries. Nanjing Hicin Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China.
Home Page: www.hicin.cn
No.1 Hengfa Road
Nanjing,
210046
China
Phone:
86 25 8322 2911
Officers
| Name | Title |
|---|---|
| Mr. Yuping Cao | GM & Chairman |
| Ms. Qinghua Liu | CFO & Financial Director |
| Ms. Xiaomin Yao | Deputy GM & Director |
| Mr. Yongjun Wang | Deputy GM & Director |
| Mr. Weicheng Liu | Deputy Gen. Mang. |
Exchange: SHE
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 13.7229 |
| Price-to-Book MRQ: | 4.4161 |
| Price-to-Sales TTM: | 9.0927 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 563 |